Iris Pharma   Report issue

For profit Phase 2 Phase 4
Founded: La Gaude France (1989)

Organization Overview

First Clinical Trial
2017
NCT03009799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Iris Pharma | IRIS Research and Development, LLC

Active Ingredients

Drugs in Phase 4 Trials (1)

corticotropin (acthar) (1 trial)

Drugs in Phase 2 Trials (2)

carrageenan (1 trial)

cellulose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Conjunctivitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3